Mechanistic PKPD Models of Protein Therapeutics for Early Clinical Development
Fei Hua, Ph.D.; Daniel Kirouac, Ph.D.; Lore Gruenbaum, Ph.D.; John Burke, Ph.D.; Joshua Apgar, Ph.D. AAPS News Magazine (2018).
Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1
Joshua F. Apgar , Jian-Ping Tang, Pratap Singh, Nanda Balasubramanian, John Burke, Michael R. Hodges, Melissa A. Lasaro, Lin Lin, Bjorn L. Miliard, Kristi Moore, Lucy S. Jun, Susan Sobolov, Anna Katharina Wilkins and Xiang Gao (2018).
BI 885578, a Novel IGF1R/INSR Tyrosine Kinase Inhibitor with Pharmacokinetic Properties That Dissociate Antitumor Efficacy and Perturbation of Glucose Homeostasis
Sanderson MP, Apgar J, Garin-Chesa P, Hofmann MH, Kessler D, Quant J, Savchenko A, Schaaf O, Treu M, Tye H, Zahn SK, Zoephel A, Haaksma E, Adolf GR, Kraut N. (2015).
PMID: 26438154
An Introduction to the Regulatory and Nonclinical Aspects of the Nonclinical Development of Antibody Drug Conjugates
Lansita J. A., Burke J. M., Apgar J. F., Mounho-Zamora B. (2015).
PMID: 26108879
Spontaneous dormancy of metastatic breast cancer cells in an all human liver microphysiologic system
1. S. E. Wheeler, A. M. Clark, D. P. Taylor, C. L. Young, V. C. Pillai, D. B. Stolz, R. Venkataramanan, D. Lauffenburger, L. Griffith, A. Wells (2014).
PMID: 25314052
A Microphysiological System Model of Metastasis Therapy
AM Clark, JT Borenstein, M. Ebrahimkhani, I. Fox, L. Griffith, W. Inman, D. Lauffenburger, T. Nguyen, R. Prantil-Baun, D. Stolz, D. Taylor, T. Ulrich, C. Pillai, R. Venkataramanan, A. Wells, SE Wheeler, C. Young (2014).
PMID: 24821820
Approaches to in vitro tissue regeneration with application for human disease modeling and drug development
M. R. Ebrahimkhani, C. L. Young, D. A. Lauffenburger, L. G. Griffith, J. T. Borenstein (2014).
PMID: 24793141